These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8302471)
21. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. Berard M; Chantome R; Marcelli A; Boffa MC J Rheumatol; 1996 Aug; 23(8):1369-74. PubMed ID: 8856615 [TBL] [Abstract][Full Text] [Related]
22. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome. de Souza AW; Silva NP; de Carvalho JF; D'Almeida V; Noguti MA; Sato EI Lupus; 2007; 16(10):782-7. PubMed ID: 17895300 [TBL] [Abstract][Full Text] [Related]
23. Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: seronegative antiphospholipid-like syndrome. Duval A; Darnige L; Glowacki F; Copin MC; Martin De Lassalle E; Delaporte E; Auxenfants E J Am Acad Dermatol; 2009 Dec; 61(6):1076-8. PubMed ID: 19646781 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of the mTORC pathway in the antiphospholipid syndrome. Canaud G; Bienaimé F; Tabarin F; Bataillon G; Seilhean D; Noël LH; Dragon-Durey MA; Snanoudj R; Friedlander G; Halbwachs-Mecarelli L; Legendre C; Terzi F N Engl J Med; 2014 Jul; 371(4):303-12. PubMed ID: 25054716 [TBL] [Abstract][Full Text] [Related]
25. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome. Sanmarco M; Boffa MC Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793 [TBL] [Abstract][Full Text] [Related]
26. Platelets and the antiphospholipid syndrome. Urbanus RT; Derksen RH; de Groot PG Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053 [TBL] [Abstract][Full Text] [Related]
27. Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies. Vaidya S; Wang CC; Gugliuzza C; Fish JC Clin Transplant; 1998 Oct; 12(5):439-44. PubMed ID: 9787955 [TBL] [Abstract][Full Text] [Related]
28. Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. Atsumi T; Khamashta MA; Andujar C; Leandro MJ; Amengual O; Ames PR; Hughes GR J Rheumatol; 1998 Jan; 25(1):69-73. PubMed ID: 9458205 [TBL] [Abstract][Full Text] [Related]
29. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780 [TBL] [Abstract][Full Text] [Related]
30. Mesenterial thrombosis with the antiphospholipid syndrome. Galarza-Maldonado C; Serrano-Alvarado P Isr Med Assoc J; 2006 Dec; 8(12):858. PubMed ID: 17214105 [No Abstract] [Full Text] [Related]
31. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Asherson RA; Cervera R; Merrill JT; Erkan D Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305 [TBL] [Abstract][Full Text] [Related]
33. Lupoid sclerosis: what is the role of antiphospholipid antibodies? Lima I; Melo A; Brandi IV; Costa O; Santiago M J Clin Rheumatol; 2007 Apr; 13(2):85-6. PubMed ID: 17414536 [TBL] [Abstract][Full Text] [Related]
34. [Antiphospholipid antibodies and cancer]. Scrobohaci ML Pathol Biol (Paris); 2008 Jun; 56(4):245-50. PubMed ID: 18456436 [TBL] [Abstract][Full Text] [Related]
35. [Antiphospholipid syndrome and kidney]. Roccatello D; Rossi D; Giachino O; Bazzan M; Mazzucco G G Ital Nefrol; 2007; 24(2):111-20. PubMed ID: 17458826 [TBL] [Abstract][Full Text] [Related]
36. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. Gresele P; Migliacci R; Vedovati MC; Ruffatti A; Becattini C; Facco M; Guglielmini G; Boscaro E; Mezzasoma AM; Momi S; Pengo V Thromb Res; 2009; 123(3):444-51. PubMed ID: 18617225 [TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibodies and hemodialysis vascular access thrombosis. Harwood L; Wilson B Nephrol Nurs J; 2001 Jun; 28(3):346-7. PubMed ID: 12143457 [TBL] [Abstract][Full Text] [Related]
40. Severe hemolytic uremia syndrome and antiphospholipid antibodies following bowel infection in the absence of major vascular occlusions: an example of MAPS? Sedlak T; Payer J; Horvathova D; Killinger Z; Hatalova A; Rovensky J; Asherson RA Isr Med Assoc J; 2008 Dec; 10(12):896-8. PubMed ID: 19160952 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]